311 related articles for article (PubMed ID: 17174552)
1. Signal integration and diversification through the p62 scaffold protein.
Moscat J; Diaz-Meco MT; Wooten MW
Trends Biochem Sci; 2007 Feb; 32(2):95-100. PubMed ID: 17174552
[TBL] [Abstract][Full Text] [Related]
2. The p62 scaffold regulates nerve growth factor-induced NF-kappaB activation by influencing TRAF6 polyubiquitination.
Wooten MW; Geetha T; Seibenhener ML; Babu JR; Diaz-Meco MT; Moscat J
J Biol Chem; 2005 Oct; 280(42):35625-9. PubMed ID: 16079148
[TBL] [Abstract][Full Text] [Related]
3. p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.
Yip KH; Feng H; Pavlos NJ; Zheng MH; Xu J
Am J Pathol; 2006 Aug; 169(2):503-14. PubMed ID: 16877352
[TBL] [Abstract][Full Text] [Related]
4. The LIM protein Ajuba influences interleukin-1-induced NF-kappaB activation by affecting the assembly and activity of the protein kinase Czeta/p62/TRAF6 signaling complex.
Feng Y; Longmore GD
Mol Cell Biol; 2005 May; 25(10):4010-22. PubMed ID: 15870274
[TBL] [Abstract][Full Text] [Related]
5. PB1 domain interaction of p62/sequestosome 1 and MEKK3 regulates NF-kappaB activation.
Nakamura K; Kimple AJ; Siderovski DP; Johnson GL
J Biol Chem; 2010 Jan; 285(3):2077-89. PubMed ID: 19903815
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
[TBL] [Abstract][Full Text] [Related]
7. Cell signaling and function organized by PB1 domain interactions.
Moscat J; Diaz-Meco MT; Albert A; Campuzano S
Mol Cell; 2006 Sep; 23(5):631-40. PubMed ID: 16949360
[TBL] [Abstract][Full Text] [Related]
8. p62 regulates CD40-mediated NFκB activation in macrophages through interaction with TRAF6.
Seibold K; Ehrenschwender M
Biochem Biophys Res Commun; 2015 Aug; 464(1):330-5. PubMed ID: 26133577
[TBL] [Abstract][Full Text] [Related]
9. TRAF6-mediated ubiquitination of NEMO requires p62/sequestosome-1.
Zotti T; Scudiero I; Settembre P; Ferravante A; Mazzone P; D'Andrea L; Reale C; Vito P; Stilo R
Mol Immunol; 2014 Mar; 58(1):27-31. PubMed ID: 24270048
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switch.
Long J; Gallagher TR; Cavey JR; Sheppard PW; Ralston SH; Layfield R; Searle MS
J Biol Chem; 2008 Feb; 283(9):5427-40. PubMed ID: 18083707
[TBL] [Abstract][Full Text] [Related]
11. Structure and functional properties of the ubiquitin binding protein p62.
Geetha T; Wooten MW
FEBS Lett; 2002 Feb; 512(1-3):19-24. PubMed ID: 11852044
[TBL] [Abstract][Full Text] [Related]
12. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation.
Seibenhener ML; Babu JR; Geetha T; Wong HC; Krishna NR; Wooten MW
Mol Cell Biol; 2004 Sep; 24(18):8055-68. PubMed ID: 15340068
[TBL] [Abstract][Full Text] [Related]
13. The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation.
Sanz L; Sanchez P; Lallena MJ; Diaz-Meco MT; Moscat J
EMBO J; 1999 Jun; 18(11):3044-53. PubMed ID: 10356400
[TBL] [Abstract][Full Text] [Related]
14. Sequestosome 1/p62--more than just a scaffold.
Seibenhener ML; Geetha T; Wooten MW
FEBS Lett; 2007 Jan; 581(2):175-9. PubMed ID: 17188686
[TBL] [Abstract][Full Text] [Related]
15. Emerging role of p62/sequestosome-1 in the pathogenesis of Alzheimer's disease.
Salminen A; Kaarniranta K; Haapasalo A; Hiltunen M; Soininen H; Alafuzoff I
Prog Neurobiol; 2012 Jan; 96(1):87-95. PubMed ID: 22138392
[TBL] [Abstract][Full Text] [Related]
16. RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis.
Gohda J; Akiyama T; Koga T; Takayanagi H; Tanaka S; Inoue J
EMBO J; 2005 Feb; 24(4):790-9. PubMed ID: 15678102
[TBL] [Abstract][Full Text] [Related]
17. TAK1-binding protein 2 facilitates ubiquitination of TRAF6 and assembly of TRAF6 with IKK in the IL-1 signaling pathway.
Kishida S; Sanjo H; Akira S; Matsumoto K; Ninomiya-Tsuji J
Genes Cells; 2005 May; 10(5):447-54. PubMed ID: 15836773
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in Paget's disease of bone.
Najat D; Garner T; Hagen T; Shaw B; Sheppard PW; Falchetti A; Marini F; Brandi ML; Long JE; Cavey JR; Searle MS; Layfield R
J Bone Miner Res; 2009 Apr; 24(4):632-42. PubMed ID: 19049332
[TBL] [Abstract][Full Text] [Related]
19. p62 mutations, ubiquitin recognition and Paget's disease of bone.
Layfield R; Cavey JR; Najat D; Long J; Sheppard PW; Ralston SH; Searle MS
Biochem Soc Trans; 2006 Nov; 34(Pt 5):735-7. PubMed ID: 17052185
[TBL] [Abstract][Full Text] [Related]
20. Essential role of sequestosome 1/p62 in regulating accumulation of Lys63-ubiquitinated proteins.
Wooten MW; Geetha T; Babu JR; Seibenhener ML; Peng J; Cox N; Diaz-Meco MT; Moscat J
J Biol Chem; 2008 Mar; 283(11):6783-9. PubMed ID: 18174161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
